BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 15472198)

  • 1. Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood.
    Link K; Moëll C; Garwicz S; Cavallin-Ståhl E; Björk J; Thilén U; Ahrén B; Erfurth EM
    J Clin Endocrinol Metab; 2004 Oct; 89(10):5003-12. PubMed ID: 15472198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement in cardiac systolic function and reduced prevalence of metabolic syndrome after two years of growth hormone (GH) treatment in GH-deficient adult survivors of childhood-onset acute lymphoblastic leukemia.
    Follin C; Thilén U; Ahrén B; Erfurth EM
    J Clin Endocrinol Metab; 2006 May; 91(5):1872-5. PubMed ID: 16522695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utility of the growth hormone (GH) releasing hormone-arginine test for diagnosing GH deficiency in adults with childhood acute lymphoblastic leukemia treated with cranial irradiation.
    Björk J; Link K; Erfurth EM
    J Clin Endocrinol Metab; 2005 Nov; 90(11):6048-54. PubMed ID: 16131575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The growth hormone (GH) response to the arginine plus GH-releasing hormone test is correlated to the severity of lipid profile abnormalities in adult patients with GH deficiency.
    Colao A; Cerbone G; Pivonello R; Aimaretti G; Loche S; Di Somma C; Faggiano A; Corneli G; Ghigo E; Lombardi G
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1277-82. PubMed ID: 10199767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular risk, cardiac function, physical activity, and quality of life with and without long-term growth hormone therapy in adult survivors of childhood acute lymphoblastic leukemia.
    Follin C; Thilén U; Osterberg K; Björk J; Erfurth EM
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3726-35. PubMed ID: 20484480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The usefulness of the combined growth hormone (GH)-releasing hormone and arginine stimulation test in the diagnosis of radiation-induced GH deficiency is dependent on the post-irradiation time interval.
    Darzy KH; Aimaretti G; Wieringa G; Gattamaneni HR; Ghigo E; Shalet SM
    J Clin Endocrinol Metab; 2003 Jan; 88(1):95-102. PubMed ID: 12519836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac mass and function, carotid artery intima-media thickness, and lipoprotein levels in growth hormone-deficient adolescents.
    Lanes R; Gunczler P; Lopez E; Esaa S; Villaroel O; Revel-Chion R
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1061-5. PubMed ID: 11238486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survivors of childhood acute lymphoblastic leukaemia, with radiation-induced GH deficiency, exhibit hyperleptinaemia and impaired insulin sensitivity, unaffected by 12 months of GH treatment.
    Bülow B; Link K; Ahrén B; Nilsson AS; Erfurth EM
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):683-91. PubMed ID: 15579181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired cardiac performance in elderly patients with growth hormone deficiency.
    Colao A; Cuocolo A; Di Somma C; Cerbone G; Della Morte AM; Nicolai E; Lucci R; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 1999 Nov; 84(11):3950-5. PubMed ID: 10566633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GH peak response to GHRH-arginine: relationship to insulin resistance and other cardiovascular risk factors in a population of adults aged 50-90.
    Carmichael JD; Danoff A; Milani D; Roubenoff R; Lesser ML; Livote E; Reitz RE; Ferris S; Kleinberg DL
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):169-77. PubMed ID: 16886956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body composition in young adult survivors of childhood acute lymphoblastic leukaemia.
    Jarfelt M; Lannering B; Bosaeus I; Johannsson G; Bjarnason R
    Eur J Endocrinol; 2005 Jul; 153(1):81-9. PubMed ID: 15994749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GHRH plus arginine in the diagnosis of acquired GH deficiency of childhood-onset.
    Maghnie M; Cavigioli F; Tinelli C; Autelli M; Aricò M; Aimaretti G; Ghigo E
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2740-4. PubMed ID: 12050243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cardiovascular risk of GH-deficient adolescents.
    Colao A; Di Somma C; Salerno M; Spinelli L; Orio F; Lombardi G
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3650-5. PubMed ID: 12161490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults.
    Cuneo RC; Judd S; Wallace JD; Perry-Keene D; Burger H; Lim-Tio S; Strauss B; Stockigt J; Topliss D; Alford F; Hew L; Bode H; Conway A; Handelsman D; Dunn S; Boyages S; Cheung NW; Hurley D
    J Clin Endocrinol Metab; 1998 Jan; 83(1):107-16. PubMed ID: 9435425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long term survivors of childhood brain cancer have an increased risk for cardiovascular disease.
    Heikens J; Ubbink MC; van der Pal HP; Bakker PJ; Fliers E; Smilde TJ; Kastelein JJ; Trip MD
    Cancer; 2000 May; 88(9):2116-21. PubMed ID: 10813724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved cardiovascular risk factors and cardiac performance after 12 months of growth hormone (GH) replacement in young adult patients with GH deficiency.
    Colao A; di Somma C; Cuocolo A; Spinelli L; Tedesco N; Pivonello R; Bonaduce D; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 2001 May; 86(5):1874-81. PubMed ID: 11344175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discontinuation of growth hormone (GH) treatment: metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects. Swedish Study Group for Growth Hormone Treatment in Children.
    Johannsson G; Albertsson-Wikland K; Bengtsson BA
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4516-24. PubMed ID: 10599711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperleptinaemia in young adults following cranial irradiation in childhood: growth hormone deficiency or leptin insensitivity?
    Brennan BM; Rahim A; Blum WF; Adams JA; Eden OB; Shalet SM
    Clin Endocrinol (Oxf); 1999 Feb; 50(2):163-9. PubMed ID: 10396357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular consequences of early-onset growth hormone excess.
    Colao A; Spinelli L; Cuocolo A; Spiezia S; Pivonello R; di Somma C; Bonaduce D; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3097-104. PubMed ID: 12107207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retesting young adults with childhood-onset growth hormone (GH) deficiency with GH-releasing-hormone-plus-arginine test.
    Aimaretti G; Baffoni C; Bellone S; Di Vito L; Corneli G; Arvat E; Benso L; Camanni F; Ghigo E
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3693-9. PubMed ID: 11061526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.